EA201690219A1 - Агонисты рецептора вазопрессина-2 - Google Patents

Агонисты рецептора вазопрессина-2

Info

Publication number
EA201690219A1
EA201690219A1 EA201690219A EA201690219A EA201690219A1 EA 201690219 A1 EA201690219 A1 EA 201690219A1 EA 201690219 A EA201690219 A EA 201690219A EA 201690219 A EA201690219 A EA 201690219A EA 201690219 A1 EA201690219 A1 EA 201690219A1
Authority
EA
Eurasian Patent Office
Prior art keywords
receptor agonists
vazopressina
nocturia
vasopressin
treatment
Prior art date
Application number
EA201690219A
Other languages
English (en)
Other versions
EA029392B1 (ru
Inventor
Казимеж ВИСНЕВСКИ
Клаудио Штайнгарт
Пьер РИВЬЕР
Original Assignee
Ферринг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ферринг Б.В. filed Critical Ферринг Б.В.
Publication of EA201690219A1 publication Critical patent/EA201690219A1/ru
Publication of EA029392B1 publication Critical patent/EA029392B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)

Abstract

Агонисты рецептора вазопрессина-2, их фармацевтические композиции и способы применения вышеуказанных для лечения несахарного диабета, первичного ночного энуреза и никтурии.
EA201690219A 2013-07-26 2014-07-25 Агонисты рецептора вазопрессина-2 EA029392B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361859024P 2013-07-26 2013-07-26
US201461952073P 2014-03-12 2014-03-12
PCT/US2014/048317 WO2015013690A1 (en) 2013-07-26 2014-07-25 Vasopressin-2 receptor agonists

Publications (2)

Publication Number Publication Date
EA201690219A1 true EA201690219A1 (ru) 2016-11-30
EA029392B1 EA029392B1 (ru) 2018-03-30

Family

ID=51398870

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690219A EA029392B1 (ru) 2013-07-26 2014-07-25 Агонисты рецептора вазопрессина-2

Country Status (28)

Country Link
US (2) US10131692B2 (ru)
EP (1) EP3024829B1 (ru)
JP (1) JP6387095B2 (ru)
KR (1) KR102198130B1 (ru)
CN (1) CN105492441B (ru)
AU (1) AU2014292860B2 (ru)
BR (1) BR112016000436B1 (ru)
CA (1) CA2919208A1 (ru)
DK (1) DK3024829T3 (ru)
EA (1) EA029392B1 (ru)
ES (1) ES2656039T3 (ru)
HK (1) HK1218647A1 (ru)
HR (1) HRP20180009T1 (ru)
HU (1) HUE035252T2 (ru)
IL (1) IL243730B (ru)
JO (1) JO3371B1 (ru)
LT (1) LT3024829T (ru)
MX (1) MX363355B (ru)
MY (1) MY183429A (ru)
PH (1) PH12016500044A1 (ru)
PL (1) PL3024829T3 (ru)
PT (1) PT3024829T (ru)
RS (1) RS56604B1 (ru)
SG (1) SG11201600031RA (ru)
SI (1) SI3024829T1 (ru)
TW (1) TWI640542B (ru)
WO (1) WO2015013690A1 (ru)
ZA (1) ZA201600145B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343982B1 (en) 2008-09-17 2017-03-22 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
MA46586A (fr) 2016-10-21 2019-08-28 Chiasma Inc Compositions de terlipressine et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE399252B (sv) * 1976-05-24 1978-02-06 Ferring Ab Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
DK153883A (da) 1982-04-20 1983-10-21 Ceskoslovenska Akademie Ved Vasopressin-analoge
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
CZ292131B6 (cs) 2000-02-16 2003-08-13 Ústav organické chemie a biochemie AV ČR Synthetické analogy Desmopressinu chráněné v C-terminální sekvenci proti karboxyamidasovému štěpení

Also Published As

Publication number Publication date
EA029392B1 (ru) 2018-03-30
PL3024829T3 (pl) 2018-04-30
AU2014292860A1 (en) 2016-01-28
IL243730B (en) 2019-09-26
RS56604B1 (sr) 2018-02-28
PH12016500044B1 (en) 2016-03-28
TWI640542B (zh) 2018-11-11
CA2919208A1 (en) 2015-01-29
KR20160034943A (ko) 2016-03-30
WO2015013690A1 (en) 2015-01-29
SG11201600031RA (en) 2016-02-26
MX363355B (es) 2019-03-21
PT3024829T (pt) 2017-12-18
TW201536815A (zh) 2015-10-01
HRP20180009T1 (hr) 2018-02-09
IL243730A0 (en) 2016-04-21
US10131692B2 (en) 2018-11-20
NZ716342A (en) 2021-03-26
US20190194257A1 (en) 2019-06-27
JP6387095B2 (ja) 2018-09-05
EP3024829A1 (en) 2016-06-01
CN105492441A (zh) 2016-04-13
HUE035252T2 (en) 2018-05-02
CN105492441B (zh) 2019-09-10
JP2016527255A (ja) 2016-09-08
KR102198130B1 (ko) 2021-01-05
ZA201600145B (en) 2020-01-29
DK3024829T3 (en) 2017-12-04
JO3371B1 (ar) 2019-03-13
HK1218647A1 (zh) 2017-03-03
MX2016000525A (es) 2016-04-07
LT3024829T (lt) 2017-12-27
US10745443B2 (en) 2020-08-18
SI3024829T1 (en) 2018-01-31
US20150307555A1 (en) 2015-10-29
AU2014292860B2 (en) 2017-10-05
BR112016000436A2 (ru) 2017-07-25
MY183429A (en) 2021-02-18
PH12016500044A1 (en) 2016-03-28
ES2656039T3 (es) 2018-02-22
BR112016000436B1 (pt) 2022-07-05
EP3024829B1 (en) 2017-11-08

Similar Documents

Publication Publication Date Title
CY1122796T1 (el) Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων
ECSP17016797A (es) Indazoles sustituidos con benzilo como inhibidores de bub1
EA201791310A1 (ru) Химерные антигенные рецепторы к bcma
EA201692201A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201391764A1 (ru) Агонисты рецептора glp-1/глюкагона длительного действия
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201690713A1 (ru) Гетероциклические соединения и их применения
EA201790785A1 (ru) Производные тетрагидроизохинолина
EA201590993A1 (ru) Гетеродимерные иммуноглобулины
EA201290940A1 (ru) Новые соединения как селективные антагонисты рецептора nk3, фармацевтическая композиция и методы их использования при нарушениях, опосредованных nk3 рецепторами
EA201591420A1 (ru) Гетероарильные соединения и их применение
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201491161A1 (ru) Фторированные модуляторы рецепторов эстрогенов и их применение
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
UY34601A (es) ?mezclas fungicidas de pirazol?.
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201891376A1 (ru) Бензотиофеновые селективные блокаторы эстрогеновых рецепторов
EA201690099A1 (ru) Устойчивая жидкая композиция, содержащая amg-416 (велкальцетид)
EA201692433A1 (ru) Соединения ppar для применения при лечении фиброзных заболеваний
PH12018502274A1 (en) Semaglutide in cardiovascular conditions
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
DK3265459T3 (da) Amidforbindelser som 5-ht4-receptoragonister

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TJ TM